Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ORAMED PHARMACEUTICALS INC. | zk1110699.htm |
| EX-31.2 - EXHIBIT 31.2 - ORAMED PHARMACEUTICALS INC. | exhibit_31-2.htm |
| EX-23.2 - EXHIBIT 23.2 - ORAMED PHARMACEUTICALS INC. | exhibit_23-2.htm |
| EX-23.1 - EXHIBIT 23.1 - ORAMED PHARMACEUTICALS INC. | exhibit_23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - ORAMED PHARMACEUTICALS INC. | exhibit_31-1.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that the Annual Report for the fiscal year ended August 31, 2011 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: November 28, 2011
|
/s/ Nadav Kidron
|
||
|
Nadav Kidron, President and Chief Executive Officer
|
|||
|
Dated: November 28, 2011
|
/s/ Yifat Zommer
|
||
|
Yifat Zommer, Chief Financial Officer
|
|||
A signed original of this written statement required by Section 906 has been provided by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.